TripleMed
Maastricht
About TripleMed
TripleMed is developing minimally invasive products against aneurysms, without the need for incisions. The first product fills the aneurysm and prevents blood from entering, whilst leaving a channel for the blood to flow through to reach the other arteries. This enables a better and longer-lasting solution to the problem of aortic aneurysms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2017)
- Website: triplemedical.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Product Research
Canonical: https://fsome.com/organization/triplemed-183169 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.